Revvity (RVTY) Competitors $103.73 +1.76 (+1.73%) Closing price 07/25/2025 03:59 PM EasternExtended Trading$104.20 +0.46 (+0.44%) As of 07/25/2025 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RVTY vs. BRKR, TECH, A, DHR, IQV, MTD, TMO, WAT, KEYS, and VLTOShould you be buying Revvity stock or one of its competitors? The main competitors of Revvity include Bruker (BRKR), Bio-Techne (TECH), Agilent Technologies (A), Danaher (DHR), IQVIA (IQV), Mettler-Toledo International (MTD), Thermo Fisher Scientific (TMO), Waters (WAT), Keysight Technologies (KEYS), and Veralto (VLTO). Revvity vs. Its Competitors Bruker Bio-Techne Agilent Technologies Danaher IQVIA Mettler-Toledo International Thermo Fisher Scientific Waters Keysight Technologies Veralto Bruker (NASDAQ:BRKR) and Revvity (NYSE:RVTY) are related companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations, earnings and media sentiment. Is BRKR or RVTY more profitable? Revvity has a net margin of 10.35% compared to Bruker's net margin of 2.31%. Bruker's return on equity of 19.47% beat Revvity's return on equity.Company Net Margins Return on Equity Return on Assets Bruker2.31% 19.47% 5.95% Revvity 10.35%7.73%4.72% Do analysts rate BRKR or RVTY? Bruker presently has a consensus price target of $52.89, suggesting a potential upside of 26.11%. Revvity has a consensus price target of $123.07, suggesting a potential upside of 18.64%. Given Bruker's higher possible upside, research analysts clearly believe Bruker is more favorable than Revvity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bruker 0 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.40Revvity 0 Sell rating(s) 4 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.73 Which has more risk & volatility, BRKR or RVTY? Bruker has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500. Comparatively, Revvity has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500. Does the media favor BRKR or RVTY? In the previous week, Bruker had 12 more articles in the media than Revvity. MarketBeat recorded 28 mentions for Bruker and 16 mentions for Revvity. Revvity's average media sentiment score of 0.97 beat Bruker's score of 0.38 indicating that Revvity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bruker 8 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Neutral Revvity 8 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is BRKR or RVTY a better dividend stock? Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.5%. Revvity pays an annual dividend of $0.28 per share and has a dividend yield of 0.3%. Bruker pays out 38.5% of its earnings in the form of a dividend. Revvity pays out 11.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Do insiders and institutionals hold more shares of BRKR or RVTY? 79.5% of Bruker shares are owned by institutional investors. Comparatively, 86.7% of Revvity shares are owned by institutional investors. 27.3% of Bruker shares are owned by company insiders. Comparatively, 0.7% of Revvity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has stronger valuation and earnings, BRKR or RVTY? Revvity has lower revenue, but higher earnings than Bruker. Revvity is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBruker$3.37B1.89$113.10M$0.5280.65Revvity$2.76B4.44$270.39M$2.3544.14 SummaryBruker and Revvity tied by winning 9 of the 18 factors compared between the two stocks. Get Revvity News Delivered to You Automatically Sign up to receive the latest news and ratings for RVTY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RVTY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVTY vs. The Competition Export to ExcelMetricRevvityMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$12.02B$7.30B$5.70B$21.05BDividend Yield0.27%2.84%4.58%3.59%P/E Ratio44.1425.8228.3928.45Price / Sales4.4435.98431.7671.70Price / Cash11.9826.7436.2222.92Price / Book1.659.718.674.68Net Income$270.39M$239.96M$3.25B$995.51M7 Day Performance11.31%2.92%4.25%1.65%1 Month Performance4.83%4.88%10.51%4.54%1 Year Performance-9.91%15.47%35.68%10.00% Revvity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVTYRevvity2.9408 of 5 stars$103.73+1.7%$123.07+18.6%-8.0%$12.02B$2.76B44.1411,000News CoverageUpcoming EarningsDividend AnnouncementAnalyst UpgradeBRKRBruker4.9683 of 5 stars$35.63-12.1%$52.89+48.4%-34.7%$6.14B$3.37B17.2511,396High Trading VolumeTECHBio-Techne4.6739 of 5 stars$50.27-3.4%$70.00+39.2%-25.3%$7.88B$1.16B61.313,100Analyst UpgradeAAgilent Technologies4.8687 of 5 stars$112.12-1.6%$139.77+24.7%-11.0%$32.38B$6.51B21.1117,900Positive NewsDHRDanaher4.8279 of 5 stars$188.23-1.0%$248.48+32.0%-23.9%$136.01B$23.88B25.5163,000Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionIQVIQVIA4.563 of 5 stars$159.06-1.0%$222.45+39.9%-14.3%$27.52B$15.41B21.6788,000Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst RevisionMTDMettler-Toledo International4.1443 of 5 stars$1,168.60-2.2%$1,280.90+9.6%-10.4%$24.28B$3.87B29.1417,300Positive NewsUpcoming EarningsTMOThermo Fisher Scientific4.954 of 5 stars$405.15-2.3%$599.30+47.9%-19.5%$152.94B$42.88B23.76125,000Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionWATWaters4.7925 of 5 stars$282.01-1.9%$381.94+35.4%-2.5%$16.78B$2.96B25.597,600Trending NewsAnalyst DowngradeHigh Trading VolumeKEYSKeysight Technologies4.0551 of 5 stars$162.86+0.2%$186.11+14.3%+22.5%$28.03B$4.98B38.2315,500VLTOVeralto3.0352 of 5 stars$102.19-1.1%$111.18+8.8%+3.8%$25.33B$5.19B29.2017,000Positive NewsUpcoming Earnings Related Companies and Tools Related Companies Bruker Alternatives Bio-Techne Alternatives Agilent Technologies Alternatives Danaher Alternatives IQVIA Alternatives Mettler-Toledo International Alternatives Thermo Fisher Scientific Alternatives Waters Alternatives Keysight Technologies Alternatives Veralto Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:RVTY) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredStrait of Hormuz = $100 Oil?Dow Drops 540 Points, Oil Soars Middle East conflict sends markets plunging, oil jumping 8.5%. Investors fl...The Oxford Club | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revvity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revvity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.